bodyType

customContents

entityId

entityUuid

articlePageQuery

filter

article

articleBaseAdvertisingInfoArticle

articleListArticle

articleSeoArticle

hooksArticleAcknowledgementGateOverlayArticle

hooksTrackPageViewArticle

hooksContentInterestArticle

articleLinkingDataContent

hooksAmpRedirectArticle

articleSchemaContent

liveArticle

advertZone

sentiment

contentLock

topics

types

sections

paywallTypes

createdDate

publishedDate

sponsorType

urlAlias

moreOnThisArticles

commentCount

authorLocations

authors

corrections

displaySlideShow

multimediaEmbed

printHeadline

seriesContainer

articleSpeeches

socialHeadline

headline

images

flag

firstTopic

glossary

flattenTypeIds

image

relatedLinks

relatedNewsletters

__typename

sponsor

pdfFiles

seriesReverseOrder

series

disableOffPlatformContent

published

updatedDate

summary

subHeadline

body

keywords

readingTime

customTimezone

liveContents

Stroke victims are being sold totally ineffective counterfeit medication on the mainland through a syndicate using Hong Kong packaging.

 The genuine manufacturer of the intravenous drug Cerebrolysin, Health Care Pharmaceuticals (China) Ltd, instigated a private investigation that led to the conviction of Lai Shu-lam, whose Forest Offset Printing Co provided thousands of printed packages and instruction leaflets for the fake drug.

 Lai was ordered yesterday to pay a $30,000 fine or face two weeks' jail for contempt of court by Mr Justice Wally Yeung Chun-kuen at the Court of First Instance.

 The judge agreed Lai had failed to hand over stocks of the packages and documents which the manufacturers hoped would lead them to a mastermind in the syndicate.

 Acting on a tip-off, Health Care Pharmaceuticals (China) Ltd obtained a court order against Lai in September ordering him to reveal the names of others involved and to hand over any counterfeit goods or documents relating to the drug's production.

 Lai said a 'walk-in' customer called Mr Cheng had paid a deposit for about 200,000 packages and he had no idea how to contact him.

 Investigations revealed Lai had hundreds of counterfeit instruction leaflets in a desk drawer, that he understated the order and that he had fulfilled another order - altogether totalling 340,000 boxes - which he did not disclose to the court.

 The judge ordered Lai to pay costs of the action along with the $30,000 fine.

 Health Care Pharmaceuticals (China) Ltd managing director George Cautherley said: 'We've seized three different counterfeit formulations - none of which contained the proper product.' 



Counterfeit stroke medication sold over border in locally-made packaging